GENI vs SRTA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

GENI

52.6
AI Score
VS
GENI Wins

SRTA

34.9
AI Score

Investment Advisor Scores

GENI

53score
Recommendation
HOLD

SRTA

35score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric GENI SRTA Winner
Forward P/E 56.8182 138.8889 GENI
PEG Ratio 0 0 Tie
Revenue Growth 64.7% 60.7% GENI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 52.6/100 34.9/100 GENI
Profit Margin -23.0% 15.7% SRTA
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL GENI

Relative Price Performance (Last 90 Days)

GENI 1M: +25.3% · 3M: +64.8% SRTA 1M: +22.6% · 3M: +7.6%

Current Technical Phase

GENI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.0% over 20 days), RSI 60

RSI (14): 59.7 · Price: $8.06

SRTA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.0 · Price: $6.24

Fundamentals Snapshot

Metric GENI SRTA
Market Cap
Forward P/E 7.5 1784.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.6% 0.6%
Gross Margin 0.3% 0.2%
Operating Margin -0.1% -0.1%
EPS -0.70 -0.28
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.